title: Refractory craniofacial actinomycetoma due to Streptomyces somaliensis that required salvage therapy with amikacin and imipenem.
authors.affiliation: Département de Maladies Infectieuses, Hôpital de la Pitié-Salpêtrière, and Centre National de Référence des Mycoses Humaines, des Antifongiques et des Actinomycètes, Institut Pasteur, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Baril
authors.forename: P
authors.initials: P
authors.lastname: Boiron
authors.forename: V
authors.initials: V
authors.lastname: Manceron
authors.forename: S O
authors.initials: SO
authors.lastname: Ely
authors.forename: P
authors.initials: P
authors.lastname: Jamet
authors.forename: E
authors.initials: E
authors.lastname: Favre
authors.forename: E
authors.initials: E
authors.lastname: Caumes
authors.forename: F
authors.initials: F
authors.lastname: Bricaire
mesh_terms: D000328:Adult; D000583:Amikacin / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005145:Face; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008271:Mycetoma / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy*; D016879:Salvage Therapy; D012886:Skull; D013302:Streptomyces; D013845:Thienamycins / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D015378:Imipenem; D000583:Amikacin